Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV
Por um escritor misterioso
Descrição
INOVIO COVID-19 Vaccine Trial Update - December 2020 - Penn Medicine
Inovio commences Phase I trial of DNA vaccine for Covid-19
Vaccines, Free Full-Text
Advances in the design and development of SARS-CoV-2 vaccines, Military Medical Research
Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study) - eClinicalMedicine
DNA vaccines against COVID-19: Perspectives and challenges - ScienceDirect
Vaccines for COVID‐19 - Tregoning - 2020 - Clinical & Experimental Immunology - Wiley Online Library
Phase 1 U.S. Trial of COVID-19 DNA Vaccine Enrollment Complete
Coronavirus vaccine development: from SARS and MERS to COVID-19, Journal of Biomedical Science
An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations - Bulent Kantarcioglu, Omer Iqbal, Joseph Lewis, Charles A. Carter, Meharvan Singh, Fabio Lievano
Frontiers Vaccines for COVID-19: A Systematic Review of Immunogenicity, Current Development, and Future Prospects
de
por adulto (o preço varia de acordo com o tamanho do grupo)
